Policy & Sector Insights
-
Feb 19, 2019
Ohio seeks $16m from UnitedHealth’s PBM for overcharging on drugs
STAT
Ohio officials are ratcheting up their closely watched battle with pharmacy benefit managers as the state attorney general is seeking nearly $16 million from OptumRx for allegedly failing to pass along discounts for generic drugs that were purchased by a state agency…Read More. -
Feb 19, 2019
First-In-Nation Montana Bill Would Regulate PBMs Through Insurers
Inside Health Policy
A bill that takes a unique, aggressive strategy to require pharmacy benefit managers pass drug rebates through to plans was passed out of a Montana Senate committee with only Republican support…Read More. -
Feb 7, 2019
New transparency requirements, loss of safe harbor for PBMs and drugmakers in proposed rule
Modern Healthcare
The Trump administration is calling for pharmacy benefit managers to disclose to health plans the fees that they get from drug companies for administrative services as part of a bid to boost transparency among PBMs…Read More. -
Feb 5, 2019
Trump, claiming progress in lowering drug prices, tells Congress ‘we must do more’
STAT
In his State of the Union address Tuesday, President Trump touted his administration’s work to reduce the price of prescription drugs and called on Congress to take further action…Read More. -
Feb 5, 2019
Focus on Drug Prices Likely in State of the Union, Experts Say
Medpage Today
It’s time for one of Washington’s favorite parlor games: guessing what the president will say in his State of the Union speech…Read More. -
Feb 2, 2019
Trump’s New Pharmacy Benefit Manager Rebate Rule Will Reshape Prescription Drug Prices
Forbes
On Thursday, U.S. Health and Human Services Secretary Alex Azar released a long-anticipated rule that could transform the prices that people pay for prescription drugs, and the broader pharmaceutical market…Read More. -
Jan 24, 2019
Pharmacy benefit managers marked up generic drugs for NY Medicaid, but where’d the money go?
STAT News
Amid intensifying scrutiny of medicine costs, an analysis of the New York Medicaid and pharmacy data suggests that pharmacy benefit managers are increasingly marking up generic drugs, raising questions about the extent to which the profits are passed back to the state health care program…Read More. -
Jan 15, 2019
Walmart blasts CVS drug middleman role, ends business relationship
The Columbus Dispatch
Walmart declared war on CVS when it blasted the pharmacy giant Tuesday and announced it will stop doing most business with CVS’s pharmacy benefit manager…Read More. -
Jan 11, 2019
Grassley: Finance Committee Will Discuss PBM Transparency Bill
Inside Health Policy
Senate Finance Committee Chairman Sen. Chuck Grassley (R-IA) will discuss a bill on pharmacy benefit manager transparency this session with his committee, a spokesman for the senator told Inside Health Policy…Read More.
View Archives
By Date
- February 2025 (1)
- January 2025 (2)
- December 2024 (3)
- August 2024 (2)
- July 2024 (3)
- June 2024 (2)
- April 2024 (1)
- March 2024 (4)
- February 2024 (1)
- November 2023 (3)
- October 2023 (1)
- September 2023 (2)
- August 2023 (4)
- July 2023 (4)